LeonaBio, Inc.
LONA
$7.04
-$0.98-12.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 21.27M | 18.33M | 16.68M | 19.11M | 22.63M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.77M | 42.79M | 34.18M | 39.27M | 57.89M |
| Operating Income | -54.77M | -42.79M | -34.18M | -39.27M | -57.89M |
| Income Before Tax | -141.46M | -129.41M | -105.61M | -37.72M | -59.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -141.46 | -129.41 | -105.61 | -37.72 | -59.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -141.46M | -129.41M | -105.61M | -37.72M | -59.85M |
| EBIT | -54.77M | -42.79M | -34.18M | -39.27M | -57.89M |
| EBITDA | -53.83M | -41.83M | -33.21M | -38.30M | -56.92M |
| EPS Basic | -19.72 | -20.70 | -21.31 | -9.68 | -15.46 |
| Normalized Basic EPS | -4.38 | -4.99 | -5.37 | -6.06 | -9.01 |
| EPS Diluted | -19.72 | -20.70 | -21.31 | -9.68 | -15.46 |
| Normalized Diluted EPS | -4.38 | -4.99 | -5.37 | -6.06 | -9.01 |
| Average Basic Shares Outstanding | 52.04M | 32.23M | 17.10M | 15.63M | 15.54M |
| Average Diluted Shares Outstanding | 52.04M | 32.23M | 17.10M | 15.63M | 15.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |